Hydroxylamine, a nitric oxide donor, inhibits insulin release and activates K+ATP channels

Eur J Pharmacol. 1996 Oct 17;313(3):229-35. doi: 10.1016/0014-2999(96)00515-8.

Abstract

The present study was undertaken to assess the effects of hydroxylamine, a nitric oxide (NO) donor, on ionic and secretory events in rat pancreatic islets. Hydroxylamine provoked a concentration-dependent inhibition of the glucose-induced insulin release. This inhibitory action was counteracted by glibenclamide. Moreover, hydroxylamine increased the rate of 86Rb outflow from perifused islets. This effect persisted in the absence of external Ca2+ but was impaired by glibenclamide. Hydroxylamine decreased 45Ca outflow, [Ca2+]i and insulin output from islets exposed to 16.7 mM glucose and extracellular Ca2+. By contrast, hydroxylamine did not affect the increase in 45Ca outflow and [Ca2+]i evoked by K+ depolarization. These experimental results suggest that the negative insulinotropic action of the NO donor results, at least in part, from the activation of ATP-sensitive K+ channels leading to a decrease in Ca2+ influx and [Ca2+]i. Additional mechanisms, however, could also be involved in the NO donor modulation of the secretory process.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / physiology*
  • Animals
  • Calcium / metabolism
  • Calcium / pharmacokinetics
  • Calcium Radioisotopes
  • Cytosol / metabolism
  • Female
  • Glucose / pharmacology
  • Hydroxylamine
  • Hydroxylamines / metabolism
  • Hydroxylamines / pharmacology*
  • In Vitro Techniques
  • Insulin / metabolism*
  • Insulin Secretion
  • Islets of Langerhans / drug effects*
  • Islets of Langerhans / metabolism*
  • Nitric Oxide / metabolism
  • Nitric Oxide / pharmacology*
  • Perfusion
  • Potassium Channels / drug effects*
  • Potassium Channels / physiology
  • Rats
  • Rubidium / pharmacokinetics
  • Rubidium Radioisotopes
  • Sensitivity and Specificity
  • Vasodilator Agents / metabolism
  • Vasodilator Agents / pharmacology*

Substances

  • Calcium Radioisotopes
  • Hydroxylamines
  • Insulin
  • Potassium Channels
  • Rubidium Radioisotopes
  • Vasodilator Agents
  • Hydroxylamine
  • Nitric Oxide
  • Adenosine Triphosphate
  • Glucose
  • Rubidium
  • Calcium